Amy S. Paller, MD, of Feinberg School of Medicine at Northwestern University, noted that safety is of paramount importance when choosing which systemic therapy to use to treat children with atopic dermatitis (AD).
Amy S. Paller, MD, chair of the department of dermatology at Northwestern University's Feinberg School of Medicine, noted that safety is of paramount importance when choosing which systemic therapy to use to treat children with atopic dermatitis (AD).
Specifically, Paller claimed that biologics are currently the safest to use in children, but she explained that, as more is learned about them, Janus kinase (JAK) inhibitors may take over that title in the years to come.
Conversely, Paller noted that the long-term side effects of systemic therapies are not yet known, which, she emphasized, providers must be aware of when using them to treat children with AD.
Transcript
What are the long-term risks of systemic therapy use in children with AD?
One of the factors that we need to be concerned about with systemic medications in children is that we're talking about longer term than what we may be talking about [for] an adult who's taking a medication. If we start at 2 or 3 years of age, 6 years of age, 10 years of age, we've got a few decades more, potentially, than what we might be doing in treating an adult.
So, we do pay attention to safety; that's of paramount importance in any systemic therapy we choose for children. Right now, we think that the biologics are safest, but we also may, in a few years, as we learn more about the JAK inhibitors, feel very comfortable with their use, including in children who have atopic dermatitis for years on end.
However, of course, it may take a long period of time before we know about the long-term side effects, even of the biologics, and we have to be aware of that in using them for our patients who are very young with atopic dermatitis.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Patients With COPD, PRISm at Increased All-Cause, Cause-Specific Mortality Risk
May 20th 2024Patients with chronic obstructive pulmonary disease (COPD) and/or preserved ratio impaired spirometry (PRISm) have an increased risk of all-cause and cause-specific mortality, highlighting the need for better understanding of these conditions through increased spirometry data collection.
Read More